Moleculin Biotech, Inc. (MBRX) Total Assets by Year
Moleculin Biotech, Inc. closed fiscal year 2025 with $22.1M in total assets, $7.1M in total liabilities and $15.0M in shareholder equity. This represents an increase of 30.7% from the prior fiscal year. The table below carries 11 fiscal years, from 2015 to 2025, and the quarters Moleculin Biotech, Inc. has filed alongside them.
Annual figures, oldest first. Point at a bar to read its period.
MBRX Balance Sheet by Fiscal Year
Figures are as reported in USD. Each change compares the year with the year before it, and each column links to the filing it was taken from.
| Metric | FY2510-K | FY2410-K | FY2310-K | FY2210-K | FY2110-K | FY2010-K | FY1910-K | FY1810-K | FY1710-K | FY1610-K | FY1510-K |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Total Assets | $22.1M+30.7% | $16.9M-55.7% | $38.2M-33.4% | $57.4M-31.7% | $84.1M+189.7% | $29.0M+15.0% | $25.2M+28.8% | $19.6M+0.5% | $19.5M+18.8% | $16.4M+58256.8% | $28K |
| Total Liabilities | $7.1M+24.5% | $5.7M-52.9% | $12.1M+132.2% | $5.2M+2.6% | $5.1M-54.8% | $11.3M+16.6% | $9.7M+81.9% | $5.3M+124.7% | $2.4M+65.0% | $1.4M+85.4% | $773K |
| Total Equity | $15.0M+33.9% | $11.2M-63.8% | $30.9M-40.7% | $52.2M-33.9% | $79.0M+344.8% | $17.8M+14.1% | $15.6M+9.1% | $14.3M-16.6% | $17.1M+14.4% | $15.0M+2108.1% | -$745K |
MBRX Balance Sheet by Quarter
Figures are as reported in USD. Each change compares the quarter with the same quarter a year earlier.
| Metric | Q2'2610-Q | Q1'2610-Q | Q4'2510-Q | Q3'2510-Q | Q2'2510-Q | Q1'2510-Q | Q4'2410-K | Q3'2410-Q | Q2'2410-Q | Q1'2410-Q | Q4'2310-K | Q3'2310-Q |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Total Assets | $21.1M-2.3% | $23.4M+11.2% | $22.1M+30.7% | $20.4M-13.0% | $21.6M-15.6% | $21.0M-31.9% | $16.9M-55.7% | $23.4M-40.8% | $25.6M-45.7% | $30.8M-39.6% | $38.2M-33.4% | $39.5M-39.5% |
| Total Liabilities | $9.5M-62.3% | $8.2M+13.3% | $7.1M+24.5% | $47.3M+690.1% | $25.2M+219.9% | $7.2M-22.0% | $5.7M-52.9% | $6.0M+36.4% | $7.9M+14.9% | $9.3M+72.1% | $12.1M+132.2% | $4.4M-37.0% |
| Total Equity | $11.6M+323307.8% | $15.2M+10.1% | $15.0M+33.9% | -$26.9M-254.6% | -$4K-100.0% | $13.8M-44.8% | $11.2M-63.8% | $17.4M-50.4% | $19.4M-51.8% | $25.0M-45.3% | $30.9M-40.7% | $35.1M-39.8% |
What total assets means
Total assets is everything the company owns on the balance sheet date, total liabilities is everything it owes, and the difference between them is the equity that belongs to shareholders.
More Moleculin Biotech, Inc. financials
Frequently Asked Questions
What was Moleculin Biotech, Inc.'s total assets in fiscal year 2025?
Moleculin Biotech, Inc. closed fiscal year 2025 with $22.1M in total assets, $7.1M in total liabilities and $15.0M in shareholder equity.
How fast is Moleculin Biotech, Inc.'s total assets growing?
Moleculin Biotech, Inc. (MBRX) total assets rose by 30.7% year over year, from $16.9M to $22.1M in fiscal year 2025.
How has Moleculin Biotech, Inc.'s total assets changed over the years?
Across the 11 fiscal years this page covers, Moleculin Biotech, Inc. (MBRX) total assets went from $28K in fiscal year 2015 to $22.1M in fiscal year 2025.
What was Moleculin Biotech, Inc.'s total assets in the most recent quarter?
Moleculin Biotech, Inc. (MBRX) reported $21.1M in total assets in Q2 2026. This represents a decrease of 2.3% from the same quarter a year earlier.
What does total assets mean on a financial statement?
Total assets is everything the company owns on the balance sheet date, total liabilities is everything it owes, and the difference between them is the equity that belongs to shareholders. This page lists what Moleculin Biotech, Inc. (MBRX) reported on that line in every period on record.